Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. PE Ratio 2006–2026
Current and historical P/E ratio for Regeneron Pharmaceuticals, Inc. (REGN), calculated by dividing the latest closing price by the trailing twelve-month earnings per share (EPS). As of March 31, 2026 it is 19.10.
From: 06/30/2010To: 03/31/2026
Stock Price
TTM Net EPS
PE Ratio
Regeneron Pharmaceuticals Inc. PE Ratio — FAQ
Regeneron Pharmaceuticals Inc. (REGN) pe ratio over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's pe ratio history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s pe ratio by year and by quarter, including the growth rate.